Paul Tudor Jones Johnson & Johnson Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Johnson & Johnson stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 25,000 shares of JNJ stock, worth $3.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,000

Previous 25,543 2.13%

Holding current value

$3.59 Million

Previous $3.73 Million 8.52%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $3.69 Million - $4.03 Million	25,543 New	25,543 $3.73 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $13 Million - $14.2 Million	89,328 Added 692.41%	102,229 $16 Million
Q3 2023 Nov 15, 2023	BUY	$155.75 - $174.48 $2.01 Million - $2.25 Million	12,901 New	12,901 $2.01 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $32.7 Million - $39 Million	216,183 New	216,183 $33.5 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $634,026 - $705,513	3,930 New	3,930 $642,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $6.79 Million - $7.53 Million	-43,547 Reduced 82.6%	9,175 $1.57 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $5.97 Million - $6.63 Million	36,966 Added 234.62%	52,722 $8.52 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $2.51 Million - $2.7 Million	15,756 New	15,756 $2.6 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $1.47 Million - $1.68 Million	-10,705 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $2 Million - $2.19 Million	-14,229 Reduced 57.07%	10,705 $1.59 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $2.98 Million - $3.59 Million	23,108 Added 1265.5%	24,934 $3.51 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $202,941 - $281,185	1,826 New	1,826 $239,000
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $8.5 Million - $9.76 Million	-66,662 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $8.46 Million - $9.48 Million	66,662 New	66,662 $8.63 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $431,614 - $474,693	-3,291 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $413,744 - $460,048	3,291 New	3,291 $460,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $2.2 Million - $2.59 Million	-18,120 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $3.22 Million - $3.56 Million	-26,983 Reduced 59.83%	18,120 $2.2 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $5.64 Million - $6.68 Million	45,103 New	45,103 $5.78 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $5.11 Million - $5.6 Million	-38,969 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $5.05 Million - $5.28 Million	38,969	38,969 $5.07 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $375B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account